SARS-CoV-2 IgG Levels Allow Predicting the Optimal Time Span of Convalescent Plasma Donor Suitability
Sandra Laner‐Plamberger(Paracelsus Medical University), Christoph Grabmer(Paracelsus Medical University), Lisa Weidner(Harvard University), Eva Rohde(Medical University of Graz), Christof Jungbauer(Paracelsus Medical University), Nadja Lindlbauer(Paracelsus Medical University), Laura Ombres(Paracelsus Medical University), Jan Marco Kern(University Children's Hospital Tübingen), Nina Held(Paracelsus Medical University), Simon Gänsdorfer(Austrian Red Cross), Georg Zimmermann(University of Salzburg), Fabian Föttinger(Paracelsus Medical University), Wanda Lauth(Fachhochschule Salzburg), Lukas Weseslindtner(Medical University of Vienna)
Cited by 2
Related Papers
Concise Review: Developing Best-Practice Models for the Therapeutic Use of Extracellular Vesicles
|Stem Cells Translational Medicine|2017|359
Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas
|International Journal of Mass Spectrometry|2007|276
Humanized large-scale expanded endothelial colony–forming cells function in vitro and in vivo
|Blood|2009|205
Rapid Large-Scale Expansion of Functional Mesenchymal Stem Cells from Unmanipulated Bone Marrow Without Animal Serum
|Tissue Engineering Part C Methods|2008|179
Prognostic relevance of serum lactate kinetics in critically ill patients
|Intensive Care Medicine|2018|166